Skip to main content

Post-IPO Equity Biotechnology Companies

Explore 483 biotechnology startups that raised post-ipo equity funding. Access verified founder contact information and fundraising data.

Total Companies
483
Total Funding
$2.1B
Avg Funding
$84.2M
Cities
21

Export 483 Post-IPO Equity Biotechnology Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
San Diego, United States
$55.0M
raised

Reneo Pharmaceuticals is an operator of a pharmaceutical company used to develop therapies for patients with orphan metabolic diseases.

May 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Waltham, United States
$276.0M
raised

Morphic Therapeutic is a biotechnology company that develops oral integrin therapies to treat serious chronic diseases.

May 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Quebec, Canada
$2.5M
raised

ChitogenX. is an orthopedic biotechnology company.

Apr 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Bogotá, Colombia
$600K
raised

Khiron is a medical cannabis company that promotes science, medicine, technology, innovation, and efficiency.

Mar 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$76.0M
raised

Generation Bio is a biotechnology company that develops genetic medicines to treat genetic disorders.

Mar 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 483 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Mississauga, Canada
$16.0M
raised

MedAvail focuses on the discovery, development, and commercialization of advanced nutrition products.

Mar 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Raleigh, United States
$5.0M
raised

9 Meters Biopharma is a gastrointestinal platform company focusing on patients with rare disorders and unmet needs.

Mar 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

London, United Kingdom
$34.0M
raised

Orchard Therapeutics is a biotechnology company dedicated to assisting patients through innovative gene therapies.

Mar 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$125.0M
raised

2seventy bio is an immuno-oncology cell therapy company that discovers and develops cancer therapies.

Feb 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$40.0M
raised

Omega Therapeutics offers a proprietary epigenomic programming platform.

Feb 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 483 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Red Bank, United States
$35.0M
raised

Provention Bio is a clinical stage biopharmaceutical dedicated to sourcing, developing, and commercializing novel therapeutics.

Feb 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Hamilton, Canada
$60.0M
raised

Fusion Pharmaceuticals is a clinical-stage oncology company focused on developing radiopharmaceuticals.

Feb 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

New York, United States
$230.0M
raised

Roivant Sciences is a biopharmaceutical company focused on the development of medicines and healthcare technologies to patients.

Feb 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

San Carlos, United States
$2.8M
raised

Apexigen is a clinical-stage biopharmaceutical company focused on discovering and developing a new antibody therapeutics for oncology.

Jan 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

South San Francisco, United States
$287.5M
raised

Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.

Jan 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 483 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Stockholm, Sweden
$674K
raised

Annexin Pharmaceuticals AB (publ) is a world-leading biotechnology company.

Dec 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

South San Francisco, United States
$172.4M
raised

Prothena is a clinical-stage neuroscience company focused on the discovery and development of novel therapies.

Dec 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

La Rochelle, France
$9.8M
raised

Valbiotis develops nutrition solutions to prevent cardio metabolic diseases and provides nutritional support for patients.

Nov 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Houston, United States
$8.0M
raised

Kiromic develops biomarker- and small molecule-based diagnostic and therapeutic programs for solid tumors and hematologic malignancies.

Oct 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

West Point, United States
$3.3M
raised

Cognetivity Neurosciences is a Platform technology for early, rapid and easy detection of dementia.

Oct 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 483 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
San Francisco, United States
$345.0M
raised

Dice Therapeutics is a clinical-stage biopharmaceutical company that makes medicines for chronic autoimmune and inflammatory diseases.

Oct 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$34.2M
raised

Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.

Oct 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Basel, Switzerland
$125.0M
raised

VectivBio is a biotechnology company committed to making innovative treatments for patients suffering from serious rare diseases.

Oct 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Oceanside, United States
$10.0M
raised

Therapeutic Solutions International is a biotechnology company engaged in the development of products for females.

Sep 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Redwood City, United States
$150.0M
raised

Allakos is a biotechnology company developing therapeutic antibodies targeting allergy, inflammatory and proliferative diseases.

Sep 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Showing 426 to 450 of 483 companies

Ready to Connect with Post-IPO Equity Biotechnology Startups?

Get verified founder emails, funding details, and company data for 483 post-ipo equity biotechnology companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked